ClinConnect ClinConnect Logo
Search / Trial NCT06924515

The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

Launched by MINGJIAN GE · Apr 5, 2025

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Lung Hernia Vats

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing lung resection via multiport thoracoscopic surgery:The intercostal muscles at the main incision site need to be dissected using an electrocautery knife.Intercostal incisions should be used with a retractor and an incision protector to prevent damage to intercostal nerves and blood vessels,as well as rib fractures.
  • Age greater than or equal to 18 years No history of thoracic surgery
  • Exclusion Criteria:
  • During the operation,if a patient's multiport thoracoscopic surgery needs to be converted to a thoracoscopic-assisted mini-thoracotomy,a rib retractor becomes necessary.
  • During the operation,conversion to thoracotomy or a conventional posterolateral incision may be necessary based on the specific intraoperative circumstances.
  • Uniportal thoracoscopic surgery History of ipsilateral thoracic surgery

About Mingjian Ge

Mingjian Ge is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on precision medicine, the organization conducts rigorous clinical trials across various therapeutic areas, leveraging cutting-edge methodologies and technologies. Mingjian Ge collaborates with a network of esteemed research institutions and healthcare professionals to ensure the highest standards of safety, efficacy, and regulatory compliance. By prioritizing patient-centered approaches and fostering transparency, Mingjian Ge aims to contribute significantly to the development of new treatments that address unmet medical needs.

Locations

Chongqing, Chongqing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported